As of 2025-07-15, the Fair Value of FibroGen Inc (FGEN) is -15.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.69 USD, the upside of FibroGen Inc is -305.17%.
With the market price of 7.69 USD and our fair value calculation, FibroGen Inc (FGEN) is not a good investment. Investing in FGEN stocks now will result in a potential loss of 305.17%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -189.30 | -290.00 | -293.70 | -284.23 | -47.58 | -220.96 |
| YoY growth | -145.84% | -53.20% | -1.28% | 3.22% | 83.26% | -22.77% |
| Market Cap (mil) | 24.39 |
| P/E | |
| Forward P/E |
| EPS | -3.16 |
| Avg earnings growth rate | -22.77% |
| TTM earnings | -10.01 |